Tpharm.info


Zolpidem poisoning





Acute zolpidem poisoning--analysis of 344 cases

8/13/2014
03:29 | Author: Brandon Powell

Side effects from medicine
Acute zolpidem poisoning--analysis of 344 cases

Acute zolpidem poisoning--analysis of 344 cases. Garnier R, Guerault E, Muzard D, Azoyan P, Chaumet-Riffaud AE, Efthymiou ML. Zolpidem is a new short.

Zolpidem is a new short acting hypnotic agent, first launched in France in 1988. Three hundred forty-four cases of intentional acute overdoses are reviewed retrospectively. Patients were predominantly female (70%) in their third or fourth decade. Ingested doses of zolpidem ranged between 10 and 1400 mg (one pack or less in 80%). Half of the patients ingested other substances (psychotropic drugs and alcohol) concomitantly. Signs of intoxication were observed in two thirds of the population but could be attributed to zolpidem in only 105 cases: drowsiness (N = 89) occurred at doses of 140 to 440 mg; coma (N = 4) or respiratory failure (N = 1). Other symptoms were rare (excepted vomiting, N = 7). Of the rare electrocardiographic or biological abnormalities, none appeared to be directly related to zolpidem. Therapy for intoxication was usually limited to supportive measures and/or gastric lavage. Symptoms of intoxication rapidly remitted in 91% of cases. Three percent of patients with multiple drug ingestion recovered despite severe complications during intensive care. Fatalities were reported for 6% but could not be directly linked to zolpidem. Previous published reports are confirmed: zolpidem acute overdose is generally benign and requires no specific therapeutic measures.

National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA.

Warning: The NCBI web site requires JavaScript to function. more.

Generate a file for use with external citation management software.

Comments (0)



Acute Zolpidem Poisoning Analysis of 344 Cases

6/12/2014
05:18 | Author: David Perry

Side effects from medicine
Acute Zolpidem Poisoning Analysis of 344 Cases

Zolpidem is a new short acting hypnotic agent, first launched in France in 1988. Three hundred reports of intentional poisoning with zolpidem. Most calls to.

In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your name unless you choose to type it. Allowing a website to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it.

There are many reasons why a cookie could not be set correctly. Below are the most common reasons:

This site uses cookies to improve performance. If your browser does not accept cookies, you cannot view this site.

This site uses cookies to improve performance by remembering that you are logged in when you go from page to page. To provide access without cookies would require the site to create a new session for every page you visit, which slows the system down to an unacceptable level.

This site stores nothing other than an automatically generated session ID in the cookie; no other information is captured.

Comments (0)

Acute zolpidem poisoning--analysis of 344 cases. - ResearchGate

4/11/2014
07:27 | Author: Nick Jenkins

Alprazolam zolpidem
Acute zolpidem poisoning--analysis of 344 cases. - ResearchGate

ABSTRACT Zolpidem is a new short acting hypnotic agent, first launched in France in 1988. Three hundred forty-four cases of intentional acute overdoses are.

ABSTRACT Zolpidem is a new short acting hypnotic agent, first launched in France in 1988. Three hundred forty-four cases of intentional acute overdoses are reviewed retrospectively. Patients were predominantly female (70%) in their third or fourth decade. Ingested doses of zolpidem ranged between 10 and 1400 mg (one pack or less in 80%). Half of the patients ingested other substances (psychotropic drugs and alcohol) concomitantly. Signs of intoxication were observed in two thirds of the population but could be attributed to zolpidem in only 105 cases: drowsiness (N = 89) occurred at doses of 140 to 440 mg; coma (N = 4) or respiratory failure (N = 1). Other symptoms were rare (excepted vomiting, N = 7). Of the rare electrocardiographic or biological abnormalities, none appeared to be directly related to zolpidem. Therapy for intoxication was usually limited to supportive measures and/or gastric lavage. Symptoms of intoxication rapidly remitted in 91% of cases. Three percent of patients with multiple drug ingestion recovered despite severe complications during intensive care. Fatalities were reported for 6% but could not be directly linked to zolpidem. Previous published reports are confirmed: zolpidem acute overdose is generally benign and requires no specific therapeutic measures.

Comments (0)

Overdose - Ambien (Zolpidem) Overdose - Drugs Forum

2/10/2014
09:56 | Author: Emma Coleman

Alprazolam zolpidem
Overdose - Ambien (Zolpidem) Overdose - Drugs Forum

"Acute Zolpidem Poisoning Analysis of 344 Cases" Clinical Toxicology 1994, Vol. 32, No. 4, Pages 391-404. Three hundred forty-four cases of.

Comments (0)

Zolpidem Intoxication Mimicking Narcotic Overdose Response to

10/19/2014
01:05 | Author: Kayla Henderson

Generic zolpidem manufacturers
Zolpidem Intoxication Mimicking Narcotic Overdose Response to

Abstract. Zolpidem is a recently introduced sleep-inducer which is thought to act on the central-type benzodiazepine receptors. This observation is the first report.

Skip to main page content.

Zolpidem is a recently introduced sleep-inducer which is thought to act on the central-type benzodiazepine receptors. This observation is the first report of drug poisoning with this compound. The toxic response was characterized by the development of a profound but short-lasting coma, associated with pin-point pupils and respiratory depression, as observed in a narcotic overdose. These clinical signs were not influenced by the administration of naloxone, but responded dramatically to flumazenil. Some analytical data on zolpidem toxicokinetics are presented. What's this? What's this?

Comments (0)